Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus

Dermatology Online Journal

Volumn 16, Issue 5, 2010, Pages

  Correia, Osvaldo ^a,b   Duarte, Ana Filipa ^a   Quirino, Paula ^a   Azevedo, Rosa ^c   Delgado, Luis ^b  

^a Instituto CUF   (Portugal)

^b University of Porto   (Portugal)

^c Department of Pathology   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

LORATADINE; PIMECROLIMUS; CALCINEURIN; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; TACROLIMUS;

ARTICLE; CASE REPORT; CHILD; DARIER DISEASE; DRUG MECHANISM; ERYTHEMA; FEMALE; GIEMSA STAIN; HUMAN; HUMAN TISSUE; MALE; ONSET AGE; PRESCHOOL CHILD; PUNCH BIOPSY; TELANGIECTASIA; TREATMENT DURATION; TREATMENT RESPONSE; URTICARIA PIGMENTOSA; DRUG ANTAGONISM; INFANT; PATHOLOGY;

CALCINEURIN; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; MALE; MASTOCYTOSIS, CUTANEOUS; TACROLIMUS;

EID: 77953100303     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mastocytosis in children: a protocol for management. Heide R, Beishuizen A, De Groot H, Den Hollander JC, Van Doormaal JJ, De Monchy JG, Pasmans SG, Van Gysel D, Oranje AP; Dutch National Mastocytosis Work Group. Pediatr Dermatol. 2008:25(4):493-500.
2. Akoglu G, Erkin G, Cakir B, Boztepe G, Sahin S, Karaduman A, Atakan N, Akan T, Kolemen F. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006;20:969-973.
3. Kiszewski AE, Durán-Mckinster C, Orozco-Covarrubias L, Gutiérrez-Castrellón P, Ruiz Maldonado R. Cutaneous mastocytosis in children: a clinical analysis of 71 cases. J Eur Acad Dermatol Venereol 2004;18:285-290.
4. Flageul B. Cutaneous mastocytosis. Rev Prat 2006;31:1745-1751.
5. Valent P, Escribano L, Parwaresch R, Schemmel V, Schwartz LB, Sotlar K, Sperr WR, Horny HP. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998. Int Arch Allergy Immunol 1999;120:1-7.
6. Heide R, de Waard-van der Spek FB, den Hollander JC, Tank B, Oranje AP. Efficacy of 25% dilute fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis. Dermatology 2007;214:333-335.
7. Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology 2007;215 suppl 1:45-54.
8. Ständer S, Ständer H, Seeliger S, Luger TA, Steinhoff M. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 2007;156:1020-1026.
9. Inoue T, Katoh N, Kishimoto S. Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. Acta Derm Venereol 2006;86:13-16.
10. Avshalumov K, Pichardo R, Jorizzo JL, Sangueza OP, Goldenberg G. Bullous mastocytosis: report of a patient and a brief review of the literature. Am J Dermatopathol. 2008 Oct;30(5):455-7.
11. Yoko N, Yasuyuki S, Hiroyuki M, Chika O, Ichiro K, Tatsuhiko F. Successful Treatment with FK506 Ointment for Adult-onset Mastocytosis; A Case Report. Jap J Dermatol 2005;115:2232-2235